1. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray, F. 2013 GLOBOCAN 2012 v1.0, cancer incidence and mortality worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer. Available from:
http://globocan.iarc.fr
, accessed on 02/08/2016.
2. Bruni L, Diaz M, Castellsagué X, Ferrer E, Bosch FX, de Sanjosé S (2010) Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. J Infect Dis 202(12):1789–1799
3. Fernández ME, Le YL, Fernández-Espada N, Calo WA, Savas LS, Vélez C et al (2014) Knowledge, attitudes, and beliefs about human papillomavirus (HPV) vaccination among Puerto Rican mothers and daughters, 2010: a qualitative study. Prev Chronic Dis 11:140171
4. Howlader N, Noone AM, Krapcho M, Miller D, Bishop K, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER cancer statistics review, 1975–2013, National Cancer Institute. Bethesda, MD,
http://seer.cancer.gov/csr/1975_2013/
, based on November 2015 SEER data submission, posted to the SEER web site, April 2016
5. National Institutes of Health consensus development conference statement: cervical cancer; 1996 1–3 [Online]. Available
https://consensus.nih.gov/1996/1996cervicalcancer102html
.